|
News releases may contain forward-looking statements, subject to risks and uncertainties beyond Nuvo's control. All news releases were accurate when issued. Actual results could differ materially from those expressed and Nuvo undertakes no obligation to revise the information in light of future events.
Year: 2010 : 2009 :
2008 : 2007
| December 1, 2009 |
Nuvo Announces Organizational Changes |
| November 11, 2009 |
Nuvo Announces WF10 Licensing and Development Update |
| November 5, 2009 |
Nuvo/Covidien Announce FDA Approves Pennsaid |
| October 28, 2009 |
Nuvo Announces Third Quarter Results |
| October 26, 2009 |
Nuvo Announces Response To Increased Trading Activity |
| September 1, 2009 |
Nuvo Announces Co-operative Drug Development Program with Germany's Fraunhofer Institute |
| August 7, 2009 |
Nuvo Announces Second Quarter Results |
| August 4, 2009 |
Nuvo & Covidien Announce FDA Extends Review of Pennsaid |
| June 16, 2009 |
Nuvo Announces Signing of U.S. License and Development Agreement with Covidien |
| June 9, 2009 |
Nuvo Announces Response to Increased Trading Activity |
| April 30, 2009 |
Nuvo Announces First Quarter Results |
April 23,
2009 |
Nuvo Announces Pennsaid Phase 3 Study Results to be Published in Leading International Pain Journal |
April 8,
2009 |
Nuvo Announces Warrant Incentive Program Raises $3.8 Million |
March 26,
2009 |
Nuvo Announces Warrant Incentive Program Raises $2.1 Million To Date |
| February 27,
2009 |
Nuvo Announces Fourth Quarter & Year-End Results |
| February 24,
2009 |
Nuvo Announces HTE Platform Selected as 2009 Edison Award Finalist |
| February 19,
2009 |
Nuvo Announces FDA Accepts Resubmission for Pennsaid |
January
28, 2009 |
Nuvo Announces Successful Completion of All Pennsaid Studies |
January 6,
2009 |
Nuvo Announces Warrant Incentive Program |
All news releases are in PDF format. To view the news releases you will need Adobe Acrobat Reader installed on your computer.
|
